Brice Blum

Clinical Risk Factors in Thrombolysis therapy: Telestroke Versus Nontelestroke

Thomas I. Nathaniel, Jordan Gainey, Brice Blum et al. · Journal of Stroke and Cerebrovascular Diseases · 2018 · 36 citations

Pulmonary Embolism, Thrombosis, Venous Thrombosis +9

Stroke and dyslipidemia: clinical risk factors in the telestroke versus non-telestroke

Jordan Gainey, Brice Blum, Bekah Bowie et al. · Lipids in Health and Disease · 2018 · 36 citations · Full text

In a stroke cohort with incident hypertension; are more women than men likely to be excluded from recombinant tissue-type Plasminogen Activator (rtPA)?

Jordan Gainey, Leanne Brechtel, Sarah Konklin et al. · Journal of the Neurological Sciences · 2018 · 33 citations

Stroke Cohort, Hypertension, Vascular Disease +17

Functional Outcome Measures of Recombinant Tissue Plasminogen Activator–Treated Stroke Patients in the Telestroke Technology

Jordan Gainey, Leanne Brecthtel, Brice Blum et al. · Journal of Experimental Neuroscience · 2018 · 27 citations · Full text

Effect of antihypertensive medications on thrombolysis therapy and outcomes in acute ischemic stroke patients

Tyler Fleming, Brice Blum, Benjamin Averkamp et al. · Journal of Clinical Hypertension · 2019 · 23 citations · Full text

Hypertension, Thrombolysis Therapy, Cerebrovascular Disease +20